Oxford Nanopore Technologies plc (OXFYY) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Francis Albert Van Parys CEO & Executive Director Thanks for the opportunity. Question-and-Answer Session Kallum Titchmarsh Morgan Stanley, Research Division And just before we get started, for all disclosures, please see morganstanley.com/researchdisclosures. So it feels like an exciting time for the business. But perhaps just to set the stage, can we just talk about how '26 has played out so far versus your initial expectations? Anything that has surprised you for the better, anything that's come in for the worse, and then we can dive in a little more into the business. Francis Albert Van Parys CEO & Executive Director Sure. Yes, I've been in the role now for about 7 months, made a really interesting start. I feel as excited to be with the business as I started on day 1. And we feel first half has gone reasonably well. We've had a few headwinds in the Middle East, obviously, that's not exclusive to us, but also a few headwinds in China that we've been struggling with. We don't expect those to go away immediately. They put some pressure on our first half revenues. But we feel we've got a good line of sight towards the full year and looking to get to the